Larimar Therapeutics Investors

23 investors on Angel Roster list Larimar Therapeutics in their portfolio. Most are private equity firms and venture capital firms, the most common stage is Seed and the largest groups are based in the United States.

Investors are matched on the company name in their portfolio, so companies that share the name Larimar Therapeutics can appear together.

Investors listed
23
With verified email
30%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 23 Larimar Therapeutics investors

The most complete profiles first. Showing 23 of 23.

  • Christoph LengauerVerified

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Craig MuirVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Robert TepperVerified

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • David HickmanVerified

    Private Equity Firm · United States

    Health CareHospitalsConsumer GoodsInformation Technology (IT)

    Portfolio: Bi02 Medical, Epic Healthcare Staffing, Cardiac Dimensions, Syros Pharmaceuticals and 88 more

    Verified email available

  • Debbie BakerVerified

    Private Equity Firm · United States

    Health CareHospitalsConsumer GoodsInformation Technology (IT)

    Portfolio: Bi02 Medical, Epic Healthcare Staffing, Cardiac Dimensions, Syros Pharmaceuticals and 88 more

    Verified email available

  • Josh FriedmanVerified

    Private Equity Firm · United States

    Health CareHospitalsConsumer GoodsInformation Technology (IT)

    Portfolio: Bi02 Medical, Epic Healthcare Staffing, Cardiac Dimensions, Syros Pharmaceuticals and 88 more

    Verified email available

  • Noreen RizviVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Abbie Celniker

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 54 more

    Contact details available

  • Bruce Booth

    Venture Capital, Angel/Individual

    SeedHealthcare DeliveryWellnessBiotechnologyConsumer Health

    Portfolio: Nimbus Therapeutics, Magenta Therapeutics, Bicycle Therapeutics, Miragen Therapeutics and 13 more

    Contact details available

  • Cary Pfeffer

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • George Xu

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Mark Levin

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceEducation

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Neil Exter

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Pete Hudson, M.D.

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsGeneticsWomen Founded

    Portfolio: Lassen Therapeutics, Avid Radiopharmaceuticals, Nereus Pharmaceuticals, Calistoga Pharmaceuticals and 59 more

    Contact details available

  • Adam Soller

    Private Equity Firm · United States

    Health CareHospitalsConsumer GoodsInformation Technology (IT)

    Portfolio: Bi02 Medical, Epic Healthcare Staffing, Cardiac Dimensions, Syros Pharmaceuticals and 88 more

    Contact details available

  • Bob More

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Lassen Therapeutics, Avid Radiopharmaceuticals, Nereus Pharmaceuticals, Calistoga Pharmaceuticals and 59 more

    Contact details available

  • Christopher Herr

    Private Equity Firm · United States

    Health CareHospitalsConsumer GoodsInformation Technology (IT)

    Portfolio: Bi02 Medical, Epic Healthcare Staffing, Cardiac Dimensions, Syros Pharmaceuticals and 88 more

    Contact details available

  • Hans Houser

    Private Equity Firm · United States

    Health CareHospitalsConsumer GoodsInformation Technology (IT)

    Portfolio: Bi02 Medical, Epic Healthcare Staffing, Cardiac Dimensions, Syros Pharmaceuticals and 88 more

    Contact details available

  • Kelly Moynihan

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Killu Sanborn

    Private Equity Firm · United States

    Health CareHospitalsConsumer GoodsInformation Technology (IT)

    Portfolio: Bi02 Medical, Epic Healthcare Staffing, Cardiac Dimensions, Syros Pharmaceuticals and 88 more

    Contact details available

  • Tim Bernier, CFA

    Private Equity Firm · United States

    Health CareHospitalsConsumer GoodsInformation Technology (IT)

    Portfolio: Bi02 Medical, Epic Healthcare Staffing, Cardiac Dimensions, Syros Pharmaceuticals and 88 more

    Contact details available

  • Walter Kowtoniuk

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • William Motley

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Larimar Therapeutics investors are on Angel Roster?

Angel Roster lists 23 Larimar Therapeutics investors. 7 of them (30%) include a verified email address.

What types of investors are they?

The most common investor types are Private Equity Firms (15), Venture Capital Firms (15) and Angel Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Larimar Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (10).

Where are Larimar Therapeutics investors based?

Most are based in the United States (22).

Which companies have Larimar Therapeutics investors backed?

The most-backed portfolio companies among them are Magenta Therapeutics (13), MyoKardia (12), Warp Drive Bio (12), Lotus Tissue Repair (12) and Blueprint Medicines (12).

How do I contact Larimar Therapeutics investors?

Create a free Angel Roster account to search and filter all 23, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.